Related Experiment Video
Updated: Aug 9, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
Expression of B-cell translocation gene 2 protein in normal human tissues
J Melamed1, S Kernizan, P D Walden
1Department of Biochemistry, New York University School of Medicine, NY 10010, USA.
Abstract:
The antiproliferative B-cell translocation gene 2 (BTG2(TIS21/PC3)) is emerging as an important regulator of cell cycle dynamics. BTG2(TIS21/PC3) expression increases in response to the induction of DNA damage, cell differentiation, cell quiescence, cell contact, and as part of a positive feedback mechanism in response to growth stimulation. The objective of the present study was to provide further insight into the biological function of BTG2(TIS21/PC3) by determining the expression levels and cellular localization of BTG2(TIS21/PC3) in a spectrum of normal human tissues and to determine the proliferative indices (based on Ki-67 staining) and apoptotic indices (based on TUNEL assay) in those cell populations where BTG2(TIS21/PC3) was differentially expressed. Highest levels of BTG2(TIS21/PC3) expression were seen in kidney proximal tubules, lung alveolar bronchial epithelium and in the basal cell layer of prostate acini. BTG2(TIS21/PC3) was expressed at significantly different levels within the different epithelial populations of the kidney (proximal vs distal tubules) and prostate (acinar basal cells vs lumenal cells). Moderate levels of expression were seen in the acinar cells of breast and pancreas and in the mucosal epithelium of the intestine. Low levels of expression were seen in neurons, hepatocyctes, the zona granulosa of the ovary, round spermatids and thyroid follicles. Our results therefore indicate an imperfect correlation between the terminally differentiated phenotype and BTG2(TIS21/PC3) expression, but no correlation between basal cellular proliferative or apoptotic indices and BTG2(TIS21/PC3) expression levels.
Insights
B-cell translocation gene 2 (BTG2) is a cell cycle regulator. Its expression varies across human tissues, but doesn't correlate with proliferation or apoptosis.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- B-cell translocation gene 2 (BTG2), also known as TIS21/PC3, is an antiproliferative protein.
- BTG2 is recognized as a key regulator of cell cycle dynamics.
- Its expression is induced by DNA damage, differentiation, quiescence, cell contact, and growth stimulation.
Purpose of the Study:
- To investigate the biological role of BTG2.
- To determine BTG2 expression levels and cellular localization in normal human tissues.
- To correlate BTG2 expression with proliferative (Ki-67) and apoptotic (TUNEL) indices.
Main Methods:
- Analysis of BTG2 expression and localization across various normal human tissues.
- Assessment of Ki-67 staining for proliferation.
- TUNEL assay for apoptosis detection.
Main Results:
- Highest BTG2 expression observed in kidney proximal tubules, lung bronchial epithelium, and prostate basal cells.
- Significant differences in BTG2 levels noted between kidney tubules and prostate epithelial cells.
- Moderate expression in breast, pancreas, and intestinal epithelium; low expression in neurons, hepatocytes, ovary, testes, and thyroid.
Conclusions:
- BTG2 expression shows an imperfect correlation with terminal differentiation.
- No direct correlation found between basal proliferation/apoptosis and BTG2 expression levels.
Related Concept Videos
Cell Specific Gene Expression
Reporter Genes
Commonly used reporter...
Abnormal Proliferation
General Transcription Factors
Cell Specific Gene Expression

